First Time Loading...

Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 5.88 USD 0.51%
Updated: May 7, 2024

Collplant Biotechnologies Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collplant Biotechnologies Ltd
Cash from Financing Activities Peer Comparison

Comparables:
KMDA
B
BLRX
URGN
ENTX
B
BONS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash from Financing Activities
$1.1m
CAGR 3-Years
-37%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Financing Activities
$22.7m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
B
BioLine RX Ltd
TASE:BLRX
Cash from Financing Activities
$15.1m
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
0%
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Financing Activities
$116.9m
CAGR 3-Years
92%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Financing Activities
$6m
CAGR 3-Years
14%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cash from Financing Activities
-₪1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Collplant Biotechnologies Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.1m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Cash from Financing Activities amounts to 1.1m USD.

What is Collplant Biotechnologies Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-17%

Over the last year, the Cash from Financing Activities growth was -41%. The average annual Cash from Financing Activities growth rates for Collplant Biotechnologies Ltd have been -37% over the past three years , -17% over the past five years .